Page last updated: 2024-08-23

isosorbide-5-mononitrate and Heart Diseases

isosorbide-5-mononitrate has been researched along with Heart Diseases in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (28.57)	18.7374
1990's	1 (14.29)	18.2507
2000's	3 (42.86)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daiber, A; Gori, T	1
Baeksgaard, L; Jensen, SA; Petersen, LN; Reiter, L; Sørensen, JB	1
Schneider, CA	1
Buval'tsev, VI; Gurevich, MA; Sanina, NP	1
Harf, C; Welter, R	1

Reviews

1 review(s) available for isosorbide-5-mononitrate and Heart Diseases

Article	Year
Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2009, Volume: 9, Issue:1 Topics: Animals; Drug Administration Schedule; Drug Tolerance; Heart Diseases; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Oxidative Stress; Pentaerythritol Tetranitrate; Reactive Oxygen Species; Vasodilator Agents	2009

Article

Year

Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2009, Volume: 9, Issue:1

Topics: Animals; Drug Administration Schedule; Drug Tolerance; Heart Diseases; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Oxidative Stress; Pentaerythritol Tetranitrate; Reactive Oxygen Species; Vasodilator Agents

2009

Other Studies

6 other study(ies) available for isosorbide-5-mononitrate and Heart Diseases

Article	Year
[Cardiotoxicity induced by 5-fluorouracil or capecitabine]. Ugeskrift for laeger, 2010, Jan-04, Volume: 172, Issue:1 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Heart; Heart Diseases; Humans; Isosorbide Dinitrate; Nitroglycerin; Prodrugs; Risk Factors; Vasodilator Agents	2010
[How is antianginal therapy with pentaerythritol tetranitrate executed?]. Deutsche medizinische Wochenschrift (1946), 2002, Nov-15, Volume: 127, Issue:46 Topics: Angina Pectoris; Animals; Delayed-Action Preparations; Drug Administration Schedule; Heart Diseases; Humans; Isosorbide Dinitrate; Pentaerythritol Tetranitrate; Time Factors; Vasodilator Agents	2002
[Cardiological use of mononitrates]. Klinicheskaia meditsina, 2000, Volume: 78, Issue:4 Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Heart Diseases; Humans; Isosorbide Dinitrate; Time Factors; Vasodilator Agents	2000
A symposium: Advances in nitrate therapy (Part 2). Montreux, Switzerland. The American journal of cardiology, 1990, Jun-04, Volume: 65, Issue:21 Topics: Heart Diseases; Humans; Isosorbide Dinitrate; Nitroglycerin	1990
A symposium: Advances in clinical practice of nitrate therapy. March 31, 1987, Montreux, Switzerland. Proceedings. The American journal of cardiology, 1988, Mar-25, Volume: 61, Issue:9 Topics: Heart Diseases; Humans; Isosorbide Dinitrate; Nitroglycerin	1988
Emergency treatment of severe cardiogenic pulmonary edema with intravenous isosorbide-5-mononitrate. The American journal of cardiology, 1988, Mar-25, Volume: 61, Issue:9 Topics: Acute Disease; Aged; Aged, 80 and over; Blood Pressure; Emergencies; Female; Heart Diseases; Humans; Infusions, Intravenous; Injections, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Pulmonary Edema; Respiration	1988